Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search

		Submit


Sexually Transmitted Diseases (STDs)








STDs & Infertility						Print
																Related Pages
										CDC recommends annual chlamydia and gonorrhea screening of**all sexually active women younger than 25 years, as well as older women with risk factors.**Such factors include having new or multiple sex partners, or a sex partner who has a sexually transmitted infection.crib
Chlamydia and gonorrhea are important preventable causes of pelvic inflammatory disease (PID) and infertility. Untreated, about 10-15% of women with chlamydia will develop PID. Chlamydia can also cause fallopian tube infection without any symptoms. PID and “silent” infection in the upper genital tract may cause permanent damage to the fallopian tubes, uterus, and surrounding tissues, which can lead to infertility.
In the United States, an estimated 4 million new chlamydia infections and 1.6 million new cases of gonorrhea infections occurred in 2018 alone.*
Most women infected with chlamydia or gonorrhea have no symptoms.CDC recommends annual chlamydia and gonorrhea screening of**all sexually active women younger than 25 years, as well as older women with risk factors**such as new or multiple sex partners, or a sex partner who has a sexually transmitted infection.Highlights2021 STI Treatment Guidelines
Expedited Partner Therapy
Chlamydia Screening, HEDIS and Managed Care* Chlamydia and gonorrhea are the first and second most commonly reported bacterial sexually transmitted infections in the United States. In 2022, a total of 1,649,716 cases of chlamydia and 648,056 cases of gonorrhea were reported to CDC from 50 states and the District of Columbia. The number of reported cases is lower than the estimated total number because infected people are often unaware of, and do not seek treatment for, their infections and because screening for chlamydia is still not routine in many clinical settings.
							
					
							Last Reviewed:  January 30, 2024						Source: 	Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention
					Facebook
        Twitter
        LinkedIn
        Syndicate homeSexually Transmitted Diseases (STDs)
Diseases & Related Conditionsplus icon
Bacterial Vaginosis (BV)
Chlamydia
Gonorrhea
Hepatitis
Herpes
HIV/AIDS & STDs
Human Papillomavirus (HPV)
*Mycoplasma genitalium (Mgen)*
Pelvic Inflammatory Disease (PID)
STDs & Infertility
STDs during Pregnancyplus icon
Fact Sheet
Detailed Fact Sheet
Statistics
Treatment and Care
Archive
STD Risk and Oral Sex
Syphilis
Trichomoniasis
Other STDsplus icon
Archive
Life Stages and Populationsplus icon
Adolescents and Young Adultsplus icon
Adolescents and Technology
Adolescents and STDs Fact Sheet
Gay, Bisexual and Other MSMplus icon
Gay Men & STDs Fact Sheet
Preventionplus icon
Guidance During Disruption of STD Clinical Services
Just Diagnosed?
Which STD Tests Should I Get?
STD Lowdown Infographic
Program Management & Evaluation Toolsplus icon
Effective Interventions
Gap Assessment Toolkit
Internet Partner Services Toolkit
Outbreak Response Resourcesplus icon
Congenital Syphilis HAN Template
Disseminated Gonococcal Infection HAN Template
Gonorrhea with Reduced Susceptibility HAN Template
LGV HAN Template
Practical Use of Program Evaluation
Program Operations Guidelines
S.P.A.C.E. Monkey
STD Informatics and Surveillance
Projects & Initiativesplus icon
EHE: Scaling Up HIV Prevention Services in STD Specialty Clinics
Gonococcal Isolate Surveillance Project (GISP)
Disease Interventionplus icon
Disease Intervention Training Centers
National Disease Intervention Specialists (DIS) Recognition Day
Resources
National Network of Prevention Training Centers (NNPTC)
STD PCHDplus icon
CDC DIS Workforce Development Funding
Guidance
STD Health Equityplus icon
Community Approaches to Reducing STDs
Sexual Health Cultural Competence Resources
Archive
STD Surveillance Network (SSuN)
Archive
Statisticsplus icon
STI Surveillance 2022
Gonococcal Isolate Surveillance Project Profiles
Syphilis Supplement
STI Prevalence, Incidence, and Cost Estimatesplus icon
At A Glance
Social Media Materials
Indian Health Service Reports
Social Media & Moreplus icon
The State of STIs Infographicplus icon
Customizable
HTML version
SDSB Contacts
Archive
Tools & Materialsplus icon
Brochuresplus icon
The Facts Brochures
Fact Sheets
Infographics
Provider Pocket Guides
Social Media Resources
Videos and Podcastsplus icon
Let’s Talk About Sexual Health
Safe in the City
Webinars
Widgets
Archive
Trainingplus icon
STD Prevention Courses
SASSI – SAS Training
STD Clinical Slidesplus icon
STD Clinical Slides
STD Picture Cardsplus icon
STD Picture Cards
Treatment and Screeningplus icon
Availability of STI Testing & Treatment Products
Duty to Warn
Expedited Partner Therapyplus icon
Gonorrhea Guidance
Legal Status of EPT
Legal/Policy Toolkit
Laboratory Information
Prenatal Syphilis Screening Laws
STD QCSplus icon
STD QCS Webinar Questions
STI Treatment Guidelines, 2021
A Guide to Taking a Sexual History
Additional Resources
Archive
About the Division of STD Preventionplus icon
STI Funding at Workplus icon
STI Prevention Success Stories
Success Bulletins
Strategic Plan 2022-2026
Fundingplus icon
Funding Archive
Archive See Also Pregnancy
Reproductive Health
 Social_round_twitterSTD on Twitter
Social_round_facebookSTD on Facebook


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue